
Type 2 diabetes zzso is a chronic zzso disorder that results from defects in both insulin zzso and insulin zzso An elevated rate of zzso zzso zzso production in the presence of zzso is the primary cause of zzso zzso after a zzso impaired suppression of zzso zzso production by insulin and decreased zzso zzso zzso by muscle contribute almost equally to zzso zzso In the United States, five classes of oral agents, each of which works through a different mechanism of action, are currently available to improve zzso control in patients with type 2 zzso The recently completed United Kingdom Prospective Diabetes Study zzso has shown that type 2 diabetes zzso is a progressive disorder that can be treated initially with oral agent zzso but will eventually require the addition of other oral agents, and that in many patients, insulin therapy will be needed to achieve targeted zzso zzso In the zzso improved zzso control, irrespective of the agent used zzso zzso or zzso decreased the zzso of zzso complications zzso zzso and zzso This review examines the goals of zzso therapy and reviews the mechanism of action, zzso zzso benefits, cost, and safety profile of each of the five approved classes of oral zzso A rationale for the use of these oral agents as zzso in combination with each other, and in combination with insulin is zzso 

